Submitted:
21 January 2026
Posted:
23 January 2026
You are already at the latest version
Abstract
Keywords:
Introduction
Case Presentation
Discussion
Niacin Microbiology
Etiology of Niacin deficiency
Diagnostic Challenges
Sequence of Symptom Development and Resolution
Therapeutic Considerations: Oral vs IV Niacin
Conclusion
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hegyi, J.; Schwartz, R.A.; Hegyi, V. Pellagra: dermatitis, dementia, and diarrhea. Int. J. Dermatol. 2004, 43, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Patel, P.; Rout, P. Vitamin B3. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, 2025. Updated February 29, 2024; Available online: https://www.ncbi.nlm.nih.gov/books/NBK526107/ (accessed on 15 December 2025).
- National Institutes of Health Office of Dietary Supplements. Niacin fact sheet for health professionals. National Institutes of Health. 2023. Available online: https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/ (accessed on 15 December 2025).
- World Health Organization. Micronutrient deficiencies. World Health Organization. 2023. Available online: https://www.who.int/health-topics/micronutrients (accessed on 14 December 2025).
- Redzic, Z.; Gupta, V. Pellagra. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, 2025; Available online: https://www.ncbi.nlm.nih.gov/books/NBK470550/ (accessed on 15 December 2025).
- Horwitt, M.K.; Harper, A.E.; Henderson, L.M. Niacin-tryptophan relationships for evaluating niacin equivalents. Am. J. Clin. Nutr. 1981, 34, 423–427. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.; Jacobson, E.L.; Jacobson, M.K. Position of cyclization in cyclic ADP-ribose. Biochem Biophys Res Commun. 1993, 194, 1143–1147. [Google Scholar] [CrossRef] [PubMed]
- Badawy, A.A.B. Pellagra and alcoholism: a biochemical perspective. Alcohol. Alcohol. 2014, 49, 238–250. [Google Scholar] [CrossRef] [PubMed]
- Matapandeu, G.; Dunn, R.; Pagels, P.; et al. Pellagra outbreak following bariatric surgery: a case series. Nutrients 2017, 9, 1025. [Google Scholar] [CrossRef]
- The Metabolic and Molecular Bases of Inherited Disease chapter on Hartnup disorder, 8th ed.; Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, Eds.; McGraw-Hill: New York, NY, 2001. [Google Scholar]
- Zhang, Q.; Man, X.; Wang, W.; et al. A case of alcoholic pellagra presenting with dementia and polyneuropathy. Neurol. Sci. 2022, 43, 739–741. [Google Scholar] [CrossRef] [PubMed]
- Prabhu, D.; Patel, M.; Shah, K.; et al. Pellagra: a review of diagnostic challenges. Cureus 2021, 13, e16233. [Google Scholar] [CrossRef]
- Navari, Y.; Bagheri, A.; Foreback, J. A rare case of pellagra in a chronic alcoholic. Cureus 2023, 15, e47909. [Google Scholar] [CrossRef] [PubMed]
- Castiello, R.J.; Lynch, P.J. Pellagra—reversibility of neurologic sequelae. Arch. Dermatol 1972, 105, 569–572. [Google Scholar]
- Sharma, A.; Sharma, A.; Sharma, D.D. Dementia associated with Pellagra: A rare case report. Indian. J. Psychiatry 2024, 66, 411–412. [Google Scholar] [CrossRef] [PubMed]
- Lotharius, K.C.; Ferguson, G.S.; Camargo, S.; Luck, G.; Perumareddi, P. Pellagra in complex clinical settings: a case involving bariatric surgery, Whipple procedure, and alcohol use disorder. Cureus 2025, 17, e90935. [Google Scholar] [CrossRef] [PubMed]


| Laboratory Test | Patient Value(s) | Reference Range | Interpretation |
| White Blood Cell Count (WBC) | 25,000/µL; later 26,030/µL | 4,000–11,000/µL | Marked leukocytosis |
| Neutrophils (%) | 89% | 40–70% | Neutrophilia |
| Sodium (Na+) | 127 mmol/L; later hypernatremia (155) | 135–145 mmol/L | Initial hyponatremia → later hypernatremia |
| Potassium (K+) | 6.4 mmol/L | 3.5–5.0 mmol/L | Hyperkalemia |
| Blood Urea Nitrogen (BUN) | 79 mg/dL | 7–20 mg/dL | Elevated |
| Creatinine | 6.2 mg/dL | 0.6–1.3 mg/dL | Severe acute kidney injury |
| Lactic Acid | 4.2 mmol/L; later 5.8 mmol/L | 0.5–2.2 mmol/L | Lactic acidosis |
| Thyroid-Stimulating Hormone (TSH) | 30 → 47 → 30 mIU/L | 0.4–4.5 mIU/L | Severe hypothyroidism |
| Vitamin B3 (Niacin) | <20 (units not specified) | 50–80 (laboratory dependent) | Severe deficiency |
| Vitamin B6 | 25 | 5–50 µg/L | Normal |
| Vitamin B12 | 500 | 200–900 pg/mL | Normal |
| Folic Acid | 20 | >3 ng/mL | Normal |
| Blood Cultures | MRSA; Staphylococcus epidermidis | No growth | Positive for bacteremia |
| Wound Cultures | Pseudomonas aeruginosa | No growth | Positive |
| Stool Studies | Unremarkable | Negative | Normal |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).